BECOME A VIVEVE SOLUTIONS PROVIDER

If you’re a Healthcare Professional and would like more information on becoming a Viveve Solutions Provider, please complete the brief form below & a representative will get in touch with you shortly thereafter.

This request / submission is confidential, Viveve will never share any personal data without your permission. Please see our Privacy Policy for details.

Content provided on this site may not be applicable for every region. Please abide by your regional indication as follows: The Viveve System® is indicated for treatment of the vaginal introitus, after vaginal childbirth, to improve sexual function in: Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Hong Kong, Japan, Malaysia, Mexico, Panama, Philippines, Singapore, United Arab Emirates, Uruguay, and Venezuela. The Viveve System is indicated for treatment of vaginal laxity in: Bahrain, EU, Iceland, Iran, Korea, Kuwait, Lebanon, Liechtenstein, Norway, Qatar, South Africa, Switzerland, Turkey, and Ukraine. The Viveve System is indicated for use in general surgery for electrocoagulation and hemostasis in: Korea, Peru, Taiwan, Thailand, and the United States.
Manage Your Listing
Viveve, Inc. 2018 All Rights Reserved